Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
It was approved to treat diabetes in 2017
Subsequent trials, including REWIND (dulaglutide) and LEADER (liraglutide), did not demonstrate increased retinopathy risk
Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition
Use proper technique: pinch fatty tissue, insert needle at 90-degree angle, and inject slowly over 5 seconds
US$ 26.77
US$ 27.29
US$ 22.90
US$ 27.71
US$ 28.26
US$ 20.69
US$ 24.33
